Is It Time To Review The Vaccination Strategy To Protect Adults A.pdf (306.8 kB)
Download fileIs It Time To Review The Vaccination Strategy To Protect Adults Against Invasive Pneumococcal Disease?
journal contribution
posted on 22.11.2019, 15:20 authored by Mary Corcoran, Jolita Mereckiene, Stephen Murchan, Martha McElligott, D O’Flanagan, Suzanne Cotter, Robert Cunney, Hilary HumphreysPneumococcal conjugate vaccines (PCVs) have reduced the predominant serotypes causing invasive pneumococcal disease (IPD). We assessed the impact of the paediatric 7- and 13-valent pneumococcal conjugate vaccines (PCV7 and PCV13) among older adults. We compared serotype-specific incidence rates from 2007/08 to 2016/17, expressed as incidence rate ratios (IRR). Introducing PCV7 and PCV13 into the childhood immunisation programme resulted in a decline in these serotypes in adults ≥65 years of age, with PCV7 serotypes decreasing by 85% (IRR=0.11, 95%CI: 0.05-0.22, p